Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Long COVID patients may have hormonal imbalances linked to their symptoms.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

PRP treatment improves hair density and diameter in women with androgenetic alopecia.

Women with PCOS have a higher risk of heart disease due to factors like insulin resistance and obesity.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Smoking is linked to more hair loss and premature graying compared to nonsmokers.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Dexpanthenol improves hair growth and satisfaction in women without side effects.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Certain genes are linked to skin aging, like wrinkles and pigmentation changes.

Doctors should consider SLE in males even if antinuclear antibody tests are negative.

More inclusive research is needed to effectively treat frontal fibrosing alopecia in Black patients.

Many children and teens referred to gender services receive hormone treatments, but more research is needed on their long-term care and outcomes.

Deep learning helps detect skin conditions and is advancing dermatology diagnosis and treatment.